Pharmacokinetic Drug Interactions of Commonly Used Anticancer Drugs
- 1 January 1986
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 11 (3) , 223-235
- https://doi.org/10.2165/00003088-198611030-00004
Abstract
With the use of combination chemotherapy as well as a wide range of symptomatic therapies (e.g. analgesics and antiemetics) for the treatment of patients with cancer, the field of oncology practises...Keywords
This publication has 97 references indexed in Scilit:
- CLINICAL AND PHARMACOKINETIC EVIDENCE OF A LIFE-THREATENING INTERACTION BETWEEN METHOTREXATE AND KETOPROFENThe Lancet, 1986
- Pharmacokinetics of Anticancer Drugs in ChildrenDrug Metabolism Reviews, 1983
- Drug Interactions and the Prepared ObserverNew England Journal of Medicine, 1981
- Decreased half life of cyclophosphamide in patients under continual treatmentPublished by Elsevier ,1979
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 1979
- Fluorouracil Therapy in Patients With Carcinoma of the Large BowelClinical Pharmacokinetics, 1978
- Clinical Pharmacokinetics of Methotrexate1Clinical Pharmacokinetics, 1978
- Binding of adriamycin to sulphated mucopolysaccharidesBiochemical and Biophysical Research Communications, 1978
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977
- Plasma half-life of cytosine arabinoside in patients with leukaemia—the effect of uridinePublished by Elsevier ,1975